QUALITY PHARMACEUTICAL CONSULTING SL.
Active
Registry details
- Registered office
- AVDA DE FUENCARRAL 22
- Municipality
- Alcobendas
- Province
- Madrid
- Share capital
- €35,805
- First publication
- 27 Aug 2013
- Latest act
- 7 May 2026
- Acts in the BORME
- 10
- Tax ID (NIF)
- Available through the API
Current directors and officers
| Role | Name |
|---|---|
| Sole director | TALLADA FROTTE GABRIEL PIERRE |
| Attorney-in-fact | ALVAREZ MONDEJAR ARANZAZU |
| Attorney-in-fact | ALVARO CARLOS SOTO MENGOTTI |
| Attorney-in-fact | NAVALON CANDELA ANDREA |
| Auditor | ADN AUDIT CORP SLP |
| Auditor | GUIJARRO RODRIGUEZ MARIA ISABEL |
Roles as published in BORME acts; they may not reflect changes not yet published.
Latest BORME publications
| Date | Acts | Source |
|---|---|---|
| 7 May 2026 | Appointments | Notice 219749 |
| 4 Feb 2025 | Capital increase | Notice 55721 |
| 22 Aug 2024 | Capital increase, Change of registered office | Notice 368411 |
| 5 Aug 2024 | Merger by absorption | Notice 344992 |
| 31 Jul 2024 | Terminations of appointment/Resignations, Appointments, Other items | Notice 338063 |
| 12 Dec 2023 | Appointments | Notice 527205 |
| 27 Jan 2023 | Merger by absorption | Notice 46649 |
| 21 Oct 2022 | Capital increase | Notice 463168 |
| 7 Mar 2014 | Appointments | Notice 106449 |
| 27 Aug 2013 | Terminations of appointment/Resignations | Notice 377908 |
Full history and NIF through the API
On paid plans (from Basic) the API returns the full history of acts of this company, its tax ID (NIF) when we have it, and change alerts. The free key lets you try the API with the publications of the last 7 days.
https://api.bormeapi.com/v1/companies/quality-pharmaceutical-consulting-sl
About this data
Source: AEBOE/BORME open data, derived and normalised by BORME API. Reuse is subject to the applicable AEBOE conditions. This page is not a substitute for a certificate or an extract from the Commercial Registry.
If your name appears on this page and you would like us to hide it, write to [email protected] (privacy policy).